Lawrence Marnett

June 5, 2023

Vanderbilt mourns loss of renowned clinical pharmacologist Jackson Roberts II, MD

Jackson Roberts II, MD, an internationally known clinical pharmacologist in the Vanderbilt University School of Medicine who helped define the role of lipid peroxidation and oxidative stress in human disease, died May 31 in Nashville. He was 79.

By Bill Snyder
May 4, 2023

Better adenoma detection

Fluorescent nanoparticles clearly identified colonic adenomas — precursors to colorectal cancer — in mice, and the formulation should translate to clinical use in humans.

By Sarah E. Glass
June 29, 2022

Vanderbilt University School of Medicine names renowned scholar Kuriyan as next dean of Basic Sciences

Vanderbilt has named John Kuriyan, PhD, one of the world’s leading structural biologists, as its next dean of the School of Medicine Basic Sciences.

By VUMC News and Communications
Recipients of the 2019 Dean’s Award for Exceptional Achievement in Graduate Studies are (front row, from left) Margaret Axelrod, Abigail Neininger, Alejandra Romero-Morales, Sheryl Vermudez, Demond Williams, and (back row, from left) James O’Connor, Manuel Castro, Matthew Cottam, Matthew Wleklinski, Michael Doyle and Azadeh Hadadianpour.
August 29, 2019

Exceptional graduate students honored with Dean’s Award

Eleven graduate students entering their fourth year of training have received the Dean’s Award for Exceptional Achievement in Graduate Studies.

By Leigh MacMillan
August 22, 2019

Exceptional graduate students honored with Dean’s Award

Eleven graduate students entering their fourth year of training have received the Dean’s Award for Exceptional Achievement in Graduate Studies.

By Leigh MacMillan
June 20, 2019

Potential probe for early ovarian cancer

Larry Marnett and colleagues have developed what may become the first agent for targeted PET imaging of cancer tissues, such as ovarian cancer, that express high levels of the COX-1 enzyme.

By Anivarya Kumar
February 14, 2019

The yin and yang of cell signaling

Larry Marnett and colleagues have explored the role of two enzymes in metabolizing molecules associated with cell proliferation, inflammatory processes and neurological diseases.
By Sanjay Mishra
September 6, 2018

Biomedical sciences journey starts from Simple Beginnings

Vanderbilt University School of Medicine welcomed 112 new doctoral students on Aug. 31 during the ninth annual Simple Beginnings ceremony in a Light Hall lecture room filled with family members and other well-wishers.
By Bill Snyder
August 30, 2018

Energetic gene switch

New findings link flux through glycolysis, which produces cellular energy, with transcription and gene expression via histone modification.
By Bill Snyder
June 8, 2018

$8.1 million grant funds new center to research highly aggressive form of lung cancer

A five-year National Cancer Institute grant will fund an interdisciplinary research center for the study of small cell lung cancer, a highly aggressive, incurable form of the disease.
By Bill Snyder
February 22, 2018

Mitochondrial mutations and disease

New findings suggest that oxidative stress damages mitochondrial DNA, and they link this damage to a disease state.
By Sanjay Mishra
September 14, 2017

Talking epigenetics

Ian Macara, Ph.D., left, chair of the Department of Cell and Developmental Biology, and Lawrence Marnett, Ph.D., right, dean of Basic Sciences in the School of Medicine, visited with Rockefeller University professor David Allis, Ph.D., last week prior to Allis’ Flexner Discovery Lecture on epigenetics.
By VUMC News and Communications
April 13, 2017

Vanderbilt University School of Medicine moves to eighth in NIH research funding

Vanderbilt University School of Medicine (VUSM) now ranks No. 8 in the nation among U.S. medical schools in total grant support provided through the National Institutes of Health (NIH). The new ranking raises VUSM’s standing two spots from the No. 10 position it held last year.
By John Howser